Skip to main content

ePharmacy Market to Reach USD 177,794.9 Million by 2026 | ePharmacy Industry Size, Share, Growth, Forecast

Written by Customer Service on . Posted in Mergers And Acquisitions.

Key Companies in EPharmacy Market are DocMorris, CVS Health Corporation, Express Script Holding Company, Walgreen Co., Optum Rx, Inc., Giant Eagle, Inc., Walmart Stores, Inc., Rowland Pharmacy, The Kroger Co., Other players

Pune, India, Nov. 29, 2021 (GLOBE NEWSWIRE) — Fortune Business Insights states that the global ePharmacy market is projected to reach USD 177,794.9 Million by 2026, thereby exhibiting an impressive CAGR of 17.3% during the forecast period (2019-2026). The company further states that the global market was valued at USD 49,727.7 Million in 2018. According to a published report by Fortune Business Insights, titled, “ePharmacy: Global Market Analysis, Insights and Forecast, 2019-2026,” the global ePharmacy market will witness notable growth during the forecast period due to the technological advancements based on artificial intelligence.

According to the World Bank, approximately 84% populace in Germany depend on Internet and around 75% populace in the U.S. are subscribers of the Internet, which augments the global ePharmacy market growth.


Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/epharmacy-market-100238


Increasing Adoption of E-commerce Websites to Favor Growth in Asia Pacific

Geographically, the global ePharmacy market is grouped into Asia Pacific, North America, the Middle East and Africa, Europe, and Latin America. Out of these regions, North America is expected to remain in the leading position in the global ePharmacy market during the forecast period. The growth is attributed to the rapid shift of consumers towards online retailers from offline pharmacies. Also, increasing usage of smartphones and high speed of the Internet are expected to aid North America in gaining the highest global ePharmacy market share in the forthcoming years. Furthermore, a rise in geriatric population, increasing online orders, and growing adoption of online platforms will drive the market growth in this region.

Europe and Asia Pacific, on the other hand, are projected to exhibit significantly high CAGR during the forecast period. In Europe, numerous prominent market players have begun offering products at lucrative rates. This will positively impact growth of ePharmacy market in this region. Asia Pacific, on the other hand, has been witnessing higher adoption of e-commerce websites and increasing patient pool. Moreover, the healthcare infrastructure in this region is on the verge of becoming prosperous. All these factors are anticipated to fuel ePharmacy market growth in Asia Pacific in the coming years.


To get to know more about the short-term and long-term impact of COVID-19 on this market,

Please Visit: https://www.fortunebusinessinsights.com/industry-reports/epharmacy-market-100238


List of Key Players in EPharmacy Market:

  • DocMorris
  • CVS Health Corporation
  • Express Script Holding Company
  • Walgreen Co.
  • Optum Rx, Inc.
  • Giant Eagle, Inc.
  • Walmart Stores, Inc.
  • Rowland Pharmacy
  • The Kroger Co.
  • Other players


Quick Buy – ePharmacy Market Research Report:  https://www.fortunebusinessinsights.com/checkout-page/100238


Key Market Players to Focus on Bagging Funds for Expanding Online Platforms

Several key market players operating in the global ePharmacy market have begun exploring and implementing new strategies to provide the consumers with smooth service. Fortune Business Insights has listed a few key developments that have occurred in the global ePharmacy market since the past few years:

  • Meds, a Swedish online pharmacy announced in January 2019 that it raised US$ 5.5 million in a funding round conducted by Inbox Capital, a family-owned venture capital company, headquartered in Sweden. The total amount of the startup has increased to US$ 10.5 million. Meds sells healthcare, beauty products, prescription, and non-prescription drugs. They have received permission from the Swedish Medical Product Agency to sell those. According to the company, approximately 40% of the sales come from the households in the Stockholm area as the home delivery service takes less than two hours. After receiving the funds, the company declared that it would soon expand their area of delivery to both Gothenburg and Malmö. Also, the company has planned to expand its warehouse area.
  • Rite Aid Corp, a drugstore chain in the U.S., announced that it acquired Envision Rx Options, a pharmaceutical company, headquartered in Ohio in June 2015. The acquisition would aid Rite Aid in expanding its retail healthcare platform and boost its health and wellness products. The mixture of Envision Rx’s pharmacy-related businesses and Rite Aid’s online platform would provide the consumers with vast offerings across mail-order, specialty, and retail channels.
  • 1mg, a prominent ePharmacy platform, based in India, bagged LegitScript certification from the National Association of Boards of Pharmacy in March 2019. It is a monitoring and verification service for offline and online pharmacies. By bagging it, 1mg has gained trust from numerous consumers as the certification proved the company to be safe and credible.


Ask for Customization of this Report: 

https://www.fortunebusinessinsights.com/enquiry/customization/epharmacy-market-100238


About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.


Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.